Skip to main content

Intra-arterial Delivery of Chemotherapeutic Agents

  • Chapter
  • First Online:
Pediatric Vascular Neurosurgery

Abstract

Intra-arterial chemotherapy (IAC) has been described in the treatment of retinoblastoma [1–3], sarcoma [4, 5], and malignant glioma [6, 7]. Intra-arterial chemotherapy (IAC) in these settings has generally been considered adjuvant therapy along with systemic chemotherapy, surgical resection, and/or radiation therapy. IAC is appealing given the potential to limit systemic toxicity from chemotherapeutic agents while increasing the concentration in areas of active malignancy. Within the central nervous system, the blood brain barrier (BBB) has proven to be a hurdle to the delivery of chemotherapy agents with various protocols described to help breakdown the BBB to facilitate chemotherapy delivery [8]. Within the pediatric population, IAC for the treatment of retinoblastoma (Rb) has become well studied with a good safety profile and efficacy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Reese AB, Hyman GA, Tapley ND, Forrest AW. The treatment of retinoblastoma by x-ray and triethylene melamine. AMA Arch Ophthalmol. 1958;60(5):897–906.

    Article  CAS  PubMed  Google Scholar 

  2. Yamane T, Kaneko A, Mohri M. The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma. Int J Clin Oncol. 2004;9(2):69–73.

    Article  PubMed  Google Scholar 

  3. Abramson DH, Dunkel IJ, Brodie SE, Kim JW, Gobin YP. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmology. 2008;115(8):1398–404, 1404.e1.

    Article  PubMed  Google Scholar 

  4. Anderson PM, Pearson M. Novel therapeutic approaches in pediatric and young adult sarcomas. Curr Oncol Rep. 2006;8(4):310–5.

    Article  CAS  PubMed  Google Scholar 

  5. Wilkins RM, Cullen JW, Odom L, Jamroz BA, Cullen PM, Fink K, et al. Superior survival in treatment of primary nonmetastatic pediatric osteosarcoma of the extremity. Ann Surg Oncol. 2003;10(5):498–507.

    Article  PubMed  Google Scholar 

  6. Desjardins A, Rich JN, Quinn JA, Vredenburgh J, Gururangan S, Sathornsumetee S, et al. Chemotherapy and novel therapeutic approaches in malignant glioma. Front Biosci J Virtual Libr. 2005;10:2645–68.

    Article  CAS  Google Scholar 

  7. Brambilla Bas M, Boccardo M. Intracarotid cisplatin chemotherapy for high-grade astrocytomas. J Neurosurg Sci. 1993;37(2):83–6.

    CAS  PubMed  Google Scholar 

  8. Hall WA, Doolittle ND, Daman M, Bruns PK, Muldoon L, Fortin D, et al. Osmotic blood–brain barrier disruption chemotherapy for diffuse pontine gliomas. J Neurooncol. 2006;77(3):279–84.

    Article  CAS  PubMed  Google Scholar 

  9. Broaddus E, Topham A, Singh AD. Incidence of retinoblastoma in the USA: 1975–2004. Br J Ophthalmol. 2009;93(1):21–3.

    Article  CAS  PubMed  Google Scholar 

  10. Chantada G, Schaiquevich P. Management of retinoblastoma in children: current status. Paediatr Drugs. 2015;17(3):185–98.

    Article  PubMed  Google Scholar 

  11. Broaddus E, Topham A, Singh AD. Survival with retinoblastoma in the USA: 1975–2004. Br J Ophthalmol. 2009;93(1):24–7.

    Article  CAS  PubMed  Google Scholar 

  12. Kaliki S, Shields CL. Retinoblastoma: achieving new standards with methods of chemotherapy. Indian J Ophthalmol. 2015;63(2):103–9.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Abramson DH, Marr BP, Brodie SE, Dunkel I, Palioura S, Gobin YP. Ophthalmic artery chemosurgery for less advanced intraocular retinoblastoma: five year review. PLoS ONE [Internet]. 2012 [Cited 10 June 2015];7(4). Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335846/.

    Google Scholar 

  14. Shields CL, Bianciotto CG, Jabbour P, Ramasubramanian A, Lally SE, Griffin GC, et al. Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds. Arch Ophthalmol Chic Ill 1960. 2011;129(11):1399–406.

    Google Scholar 

  15. Bakhshi S, Meel R, Radhakrishnan V. Current therapy and recent advances in the management of retinoblastoma. Indian J Med Paediatr Oncol. 2012;33(2):80.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Linn Murphree A. Intraocular retinoblastoma: the case for a new group classification. Ophthalmol Clin N Am. 2005;18(1):41–53, viii.

    Article  CAS  Google Scholar 

  17. Shields CL, Mashayekhi A, Au AK, Czyz C, Leahey A, Meadows AT, et al. The international classification of retinoblastoma predicts chemoreduction success. Ophthalmology. 2006;113(12):2276–80.

    Article  PubMed  Google Scholar 

  18. Suzuki S, Yamane T, Mohri M, Kaneko A. Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: the long-term prognosis. Ophthalmology. 2011;118(10):2081–7.

    Article  PubMed  Google Scholar 

  19. Francis JH, Gobin YP, Dunkel IJ, Marr BP, Brodie SE, Jonna G, et al. Carboplatin ± topotecan ophthalmic artery chemosurgery for intraocular retinoblastoma. PLoS ONE [Internet]. 21 Aug 2013 [Cited 10 June 2015];8(8). Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749169/.

  20. Jabbour P, Chalouhi N, Tjoumakaris S, Gonzalez LF, Dumont AS, Chitale R, et al. Pearls and pitfalls of intraarterial chemotherapy for retinoblastoma. J Neurosurg Pediatr. 2012;10(3):175–81.

    Article  PubMed  Google Scholar 

  21. Amans MR, Narvid J, Halbach VV. Intra-arterial chemotherapy for bilateral retinoblastoma via left ophthalmic artery and right anterior deep temporal artery. BMJ Case Rep. 2014;2014.

    Google Scholar 

  22. Saglam M, Sarici A, Anagnostakou V, Yildiz B, Kocer N, Islak C, et al. An alternative technique of the superselective catheterization of the ophthalmic artery for intra-arterial chemotherapy of the retinoblastoma: retrograde approach through the posterior communicating artery to the ophthalmic artery. Neuroradiology. 2014;56(9):751–4.

    Article  PubMed  Google Scholar 

  23. Abruzzo T, Patino M, Leach J, Rahme R, Geller J. Cerebral vasoconstriction triggered by sympathomimetic drugs during intra-atrerial chemotherapy. Pediatr Neurol. 2013;48(2):139–42.

    Article  PubMed  Google Scholar 

  24. Gobin YP, Dunkel IJ, Marr BP, Brodie SE, Abramson DH. Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience. Arch Ophthalmol Chic Ill 1960. 2011;129(6):732–7.

    Google Scholar 

  25. Sarici A, Kizilkilic O, Celkan T, Gode S. Blue toe syndrome as a complication of intra-arterial chemotherapy for retinoblastoma. JAMA Ophthalmol. 2013;131(6):801–2.

    Article  PubMed  Google Scholar 

  26. Peterson EC, Elhammady MS, Quintero-Wolfe S, Murray TG, Aziz-Sultan MA. Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors. J Neurosurg. 2011;114(6):1603–8.

    Article  PubMed  Google Scholar 

  27. Kato MA, Green N, O’Connell K, Till SD, Kramer DJ, Al-Khelaifi M, et al. A retrospective analysis of severe intraoperative respiratory compliance changes during ophthalmic arterial chemosurgery for retinoblastoma. Pediatr Anesth. 2015;25(6):595–602.

    Article  Google Scholar 

  28. Phillips TJ, McGuirk SP, Chahal HK, Kingston J, Robertson F, Brew S, et al. Autonomic cardio-respiratory reflex reactions and superselective ophthalmic arterial chemotherapy for retinoblastoma. Pediatr Anesth. 2013;23(10):940–5.

    Article  Google Scholar 

  29. Shields CL, Bianciotto CG, Jabbour P, Griffin GC, Ramasubramanian A, Rosenwasser R, et al. Intra-arterial chemotherapy for retinoblastoma: report No. 2, treatment complications. Arch Ophthalmol Chic Ill 1960. 2011;129(11):1407–15.

    Google Scholar 

  30. Eagle RC, Shields CL, Bianciotto C, Jabbour P, Shields JA. Histopathologic observations after intra-arterial chemotherapy for retinoblastoma. Arch Ophthalmol Chic Ill 1960. 2011;129(11):1416–21.

    Google Scholar 

  31. Vijayakrishnan R, Shields CL, Ramasubramanian A, Emrich J, Rosenwasser R, Shields JA. Irradiation toxic effects during intra-arterial chemotherapy for retinoblastoma: should we be concerned? Arch Ophthalmol Chic Ill 1960. 2010;128(11):1427–31.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lucy L. He MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

He, L.L., Thomas, A.J., Ogilvy, C.S. (2016). Intra-arterial Delivery of Chemotherapeutic Agents. In: Agrawal, A., Britz, G. (eds) Pediatric Vascular Neurosurgery. Springer, Cham. https://doi.org/10.1007/978-3-319-43636-4_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-43636-4_21

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-43634-0

  • Online ISBN: 978-3-319-43636-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics